Successful rescue therapy with the anti-CD19 antibody tafasitamab in anti-MDA5-positive interstitial lung disease suggests therapeutic effects of conventional anti-CD19 antibodies.
来源：PubMed发布日期：2026-07-08作者：Achleitner M, Kleymann A, Röber N, Koschel D, Meisterfeld S0 次点击